Skip to content

News Category: Health & Medical

Novaliq Presents Data from Second Phase 3 Trial of Investigational Treatment Cyclasol(R) (0.1% Cyclosporine Ophthalmic Solution) at the American Society of Cataract and Refractive Surgery Annual Meeting

By asianet

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol(R) water-free technology, today announced that data from the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investigational drug CyclASol(R) for the treatment of dry eye disease (DED), was presented as part of a podium symposium at the American Cataract … Continued

SonoScape S-Fetus 4.0 Release to Simplify Sonography Process

By asianet

SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest software upgrade of the company’s flagship ultrasound product offering. This technical breakthrough marks S-Fetus 4.0 as the globally first smart obstetric screening technology based on deep learning. Leveraging the deep learning techniques, the S-Fetus 4.0 Obstetric Screening Assistant allows doctors to automatically acquire … Continued

The First International COVID-19 Testing Standard Released

By asianet

According to the State Administration for Market Regulation, the International Organization for Standardization (ISO) released the first international standard specifically for the detection of SARS-CoV-2, the virus that causes COVID-19. On April 19, ISO issued “ISO/TS 5798:2022 In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 … Continued

AI Medical Service Inc. Announces 8 Billion JPY (US$70 M) Series C Financing Led by SoftBank Vision Fund 2 (SVF2)

By asianet

– First Instance of SVF2 Investing in Japanese Medical AI Company – AI Medical Service Inc. (hereinafter AIM), the Tokyo-based med-tech company using deep learning technology to develop endoscopic AI, has announced 8 billion JPY (US$70 million) of financing led by SoftBank Vision Fund 2 (SVF2) and joined by existing investors Globis Capital Partners, World … Continued

Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.

By asianet

– Trusted by 4.5 Million Monthly Users Worldwide – Ubie, Inc., a healthcare AI startup with the mission “To develop a healthcare guide for everyone,” has launched in the United States an “AI-powered symptom checker” ( https://ubiehealth.com ) that allows users to enter symptoms and discover related diseases. Image: https://kyodonewsprwire.jp/prwfile/release/M107009/202204180106/_prw_PI1fl_e08qVvYw.png Ubie, founded in Japan in … Continued

Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics

By asianet

ERS Genomics Limited (“ERS”) is pleased to confirm finalization of a license agreement with Sumitomo Pharma Co., Ltd. (“Sumitomo Pharma”) granting Sumitomo Pharma non-exclusive access to the fundamental CRISPR/Cas9 intellectual property portfolio held by ERS. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. … Continued

Confusing health requirements are stopping passengers from flying

By asianet

An international survey of people in the United States, the United Kingdom, Italy, and the Gulf reveals widespread confusion around health requirements for air travel, and fears that the aviation sector is not prepared for another global health crisis – Many people in every country surveyed say they chose not to fly in 2021 because … Continued

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

By asianet

— Terran to advance the development of two of Sanofi’s Phase 3 CNS therapeutics — Transaction includes worldwide exclusive rights for development and commercialization in all fields of use Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with … Continued